Laure Tillé

T cell–induced CSF1 promotes melanoma resistance to PD1 blockade

Natalie J. Neubert, Martina Schmittnaegel, Natacha Bordry et al. · Science Translational Medicine · 2018 · 292 citations · Full text

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures

Nicolas Gestermann, Damien Saugy, Christophe Martignier et al. · OncoImmunology · 2020 · 60 citations · Full text

T-regulatory Cell, Immunology, Immune Cell Therapy +18

Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion

Laure Tillé, Daniela Cropp, Mélanie Charmoy et al. · Nature Immunology · 2023 · 46 citations · Full text

Tumor Biology, Cancer Immunosurveillance, Transcription Factor Nfat5 +7

CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner

M.M. Leblond, Laure Tillé, Sina Nassiri et al. · Cancer Immunology Research · 2020 · 40 citations

Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients

Kaat de Jonge, Laure Tillé, João Lourenço et al. · OncoImmunology · 2021 · 32 citations · Full text

Immunology, Immune Regulation, Immune System +20